A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)
Clinical trial NCT00517049 · COMPLETED
Trial details
- NCT number
- NCT00517049
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-12-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.